Hoffman JP - Search Results

1

Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.

Brown KM, Siripurapu V, Davidson M, Cohen SJ, Konski A, Watson JC, Li T, Ciocca V, Cooper H, Hoffman JP. Brown KM, et al. Among authors: hoffman jp. Am J Surg. 2008 Mar;195(3):318-21. doi: 10.1016/j.amjsurg.2007.12.017. Am J Surg. 2008. PMID: 18308038

2

Neoadjuvant therapy and biliary decompression lower biliary and pancreatic juice vascular endothelial growth factor levels in patients with periampullary adenocarcinoma.

Berger AC, Watson JC, Ross EA, Zalatoris A, Hoffman JP. Berger AC, et al. Among authors: hoffman jp. Am Surg. 2004 Feb;70(2):169-73; discussion 173-4. Am Surg. 2004. PMID: 15011922

3

Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.

Meszoely IM, Lee JS, Watson JC, Meyers M, Wang H, Hoffman JP. Meszoely IM, et al. Among authors: hoffman jp. Am Surg. 2004 Mar;70(3):208-13; discussion 213-4. Am Surg. 2004. PMID: 15055843

4

The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.

Berger AC, Watson JC, Ross EA, Hoffman JP. Berger AC, et al. Among authors: hoffman jp. Am Surg. 2004 Mar;70(3):235-40; discussion 240. Am Surg. 2004. PMID: 15055847

5

Partial stomach-partitioning gastrojejunostomy for malignant duodenal obstruction.

Arciero CA, Joseph N, Watson JC, Hoffman JP. Arciero CA, et al. Among authors: hoffman jp. Am J Surg. 2006 Mar;191(3):428-32. doi: 10.1016/j.amjsurg.2005.10.053. Am J Surg. 2006. PMID: 16490561

6

Neoadjuvant therapy in pancreatic cancer.

Quiros RM, Brown KM, Hoffman JP. Quiros RM, et al. Among authors: hoffman jp. Cancer Invest. 2007 Jun;25(4):267-73. doi: 10.1080/07357900701206356. Cancer Invest. 2007. PMID: 17612937 Review.

7

Survival after pancreatectomy with major arterial resection and reconstruction.

Stitzenberg KB, Watson JC, Roberts A, Kagan SA, Cohen SJ, Konski AA, Hoffman JP. Stitzenberg KB, et al. Among authors: hoffman jp. Ann Surg Oncol. 2008 May;15(5):1399-406. doi: 10.1245/s10434-008-9844-y. Epub 2008 Mar 5. Ann Surg Oncol. 2008. PMID: 18320285

8

Defining venous involvement in borderline resectable pancreatic cancer.

Chun YS, Milestone BN, Watson JC, Cohen SJ, Burtness B, Engstrom PF, Haluszka O, Tokar JL, Hall MJ, Denlinger CS, Astsaturov I, Hoffman JP. Chun YS, et al. Among authors: hoffman jp. Ann Surg Oncol. 2010 Nov;17(11):2832-8. doi: 10.1245/s10434-010-1284-9. Epub 2010 Aug 20. Ann Surg Oncol. 2010. PMID: 20725860

9

Significance of pathologic response to preoperative therapy in pancreatic cancer.

Chun YS, Cooper HS, Cohen SJ, Konski A, Burtness B, Denlinger CS, Astsaturov I, Hall MJ, Hoffman JP. Chun YS, et al. Among authors: hoffman jp. Ann Surg Oncol. 2011 Dec;18(13):3601-7. doi: 10.1245/s10434-011-2086-4. Epub 2011 Sep 27. Ann Surg Oncol. 2011. PMID: 21947697

10

Impact of preoperative therapy on patterns of recurrence in pancreatic cancer.

Papavasiliou P, Hoffman JP, Cohen SJ, Meyer JE, Watson JC, Chun YS. Papavasiliou P, et al. Among authors: hoffman jp. HPB (Oxford). 2014 Jan;16(1):34-9. doi: 10.1111/hpb.12058. Epub 2013 Feb 20. HPB (Oxford). 2014. PMID: 23458131 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters